As seen in Figure , there are over 216,000 small molecule substances associated with publications in our dataset. Amongst the small molecule category, ciprofloxacin, and levofloxacin (both belonging to the quinolone class of antibiotics) have the highest number of occurrences, and this agrees with Figure wherein the number of publications for quinolones and fluoroquinolones were the highest. Other antibiotics featured in the list belong to various classes such as ß-lactam antibiotics (imipenem, ceftazidime, ampicillin, meropenem, cefepime, penicillin, etc.), aminoglycosides (amikacin), macrolides (erythromycin) among others. Among the proteins/peptides found in the field of antibacterials, a total of ~26k substances have been reported. Unsurprisingly, peptide-based antibiotics such as vancomycin -a glycopeptide antibacterial 383 exhibit the highest number of occurrences followed by the lipopeptide antimicrobial, daptomycin. Antimicrobial peptides such as cathelicidin LL-37, 385 nisin, 386 magainin 2 (MG2a) , and Streptogramin B 388 among others also feature in top protein/peptide substances. Polymers with antibacterial properties have various advantages over their small molecule counterparts such as higher efficacy, reduced toxicity, lesser environmental problems, and lesser susceptibility to antimicrobial resistance. Natural polymers such as chitosan, cellulose, and starch and synthetic polymers such as polyethylene glycol (PEG), poly (vinyl alcohol) (PVA) and polycaprolactone (PCL) are among the top-ranking polymer-based substances in this field. Metals such as silver, gold, titanium, gold, etc. feature among the top element-based substances. Substances from other categories such as ceramics, plastics, and mxenes are also used in the antibacterial field indicating substance diversity. Correlation between various substance classes and different bacterial genera is shown as a Sankey graph for journal and patent publications (Figure ). Staphylococcus, Escherichia, Pseudomonas, Klebsiella, and Bacillus have the highest number of reported substances associated with both journal and patent publications. Interestingly, greater number of protein/peptide-based substances associated with journal publications appear to be focused on Acinetobacter and Actinobacteria while for patent publications, Staphylococcus, Escherichia, and Pseudomonas are the top bacterial genera. Since antimicrobial resistance is a growing threat, the CDC has maintained a list of microbes that could be urgent antimicrobial resistance (AMR) threats, serious AMR threats, or AMR watchlist (microbes which could become serious threats in future due to their propensity of becoming multidrug resistant) in 2019. These lists serve as strategic tools to prioritize and address the most pressing antimicrobial threats. Figure represents the growth of substances associated with bacteria belonging to each of these lists, from journal and patent publications in last decade.